Citations

Showing 10 of 108104 citations.

A candle in the dark: The role of indirect evidence in emergency medicine clinical practice guidelines
Carpenter, Christopher R. , Silva, Lucas Oliveira J. e , Upadhye, Suneel , Broder, Joshua , Bellolio, Fernanda , E Silva, Lucas Oliveira J, Broder, Joshua S , Oliveira J E Silva, Lucas , Bellolio, M Fernanda , Carpenter, Christopher R

Mayo Clinic

Academic Emergency Medicine | March 29, 2022 | Volume: 29 | Issue: 5 | Pages: 674-677

10.1111/acem.14494 | PMID 35349211 Get It

An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond
Saadeh, Ruba , Ramos, Paola , Pittock, Sean J. , Willrich, Maria Alice V. , Saadeh, Ruba S, Ramos, Paola A, Pittock, S J , Willrich, Maria A , Algeciras‐Schimnich, Alicia , Flanagan, Eoin P.

Mayo Clinic

Clinical Chemistry | March 29, 2022 | Volume: 68 | Issue: 9 | Pages: 1134-1150

10.1093/clinchem/hvac061 | PMID 35934949 Get It

Abstract Background Multiple sclerosis (MS) is an immune-mediated central nervous system (CNS) inflammatory demyelinating disease in which analysis of clinical presentation, imaging studies, and laboratory tests aid in diagnosis. Content This review discusses laboratory tests ordered to rule out and rule in MS, such as the traditional measurement of cerebrospinal fluid (CSF) IgG index and oligoclonal bands. Biomarkers discovered in the past 2 decades, such as aquaporin-4 (AQP4) antibodies and myelin oligodendrocyte glycoprotein (MOG) antibodies, have been incorporated into clinical practice in the diagnosis of disorders referred to as MS mimics. The importance of test selection, assay methodology, optimal sample for testing, and diagnostic utility of these biomarkers is reviewed. Other laboratory testing that can aid in the differentiation between MS and these biomarker-defined CNS demyelinating diseases is described. There is a focus on emerging biomarkers such as the use of kappa immunoglobulin free light chain concentration in CSF and kappa CSF index measurement as an alternative to oligoclonal bands which has a potential for an improvement in laboratory workflows. Finally, the role of biomarkers of disease activity and prognosis are discussed, including neurofilament light chain, glial fibrillary acidic protein, and myelin basic protein. Future perspectives with improved laboratory testing tools and discovery of additional biomarkers are provided. Summary Laboratory testing for demyelinating disorders using CSF and serum are routine practices that can benefit from an update, as novel biomarker-defined entities have reduced the potential for MS misdiagnosis, and CSF/serum biomarkers reinstated in the diagnostic criteria of MS.
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications
Omote, Kazunori , Sorimachi, Hidemi, Obokata, Masaru , Reddy, Yogesh N.V. , Verbrugge, Frederik H. , Redfield, Margaret M. , Borlaug, Barry A. , Omar, Massar , Borlaug, Barry A , Nishimura, Rick , Obokata, Masaru , Verbrugge, Frederik H , Omar, Massar , DuBrock, Hilary M.

Mayo Clinic

European Heart Journal | March 29, 2022 | Volume: 43 | Issue: 36 | Pages: 3417-3431

10.1093/eurheartj/ehac184 | PMID 35796488 Get It

Abstract Aims Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in left heart disease (LHD). This study sought to characterize the pathophysiology of PVD across the spectrum of PH in LHD. Methods and results Patients with PH-LHD [mean pulmonary artery (PA) pressure >20 mmHg and PA wedge pressure (PAWP) ≥15 mmHg] and controls free of PH or LHD underwent invasive haemodynamic exercise testing with simultaneous echocardiography, expired air and blood gas analysis, and lung ultrasound in a prospective study. Patients with PH-LHD were divided into isolated post-capillary PH (IpcPH) and PVD [combined post- and pre-capillary PH (CpcPH)] based upon pulmonary vascular resistance (PVR <3.0 or ≥3.0 WU). As compared with controls (n = 69) and IpcPH-LHD (n = 55), participants with CpcPH-LHD (n = 40) displayed poorer left atrial function and more severe right ventricular (RV) dysfunction at rest. With exercise, patients with CpcPH-LHD displayed similar PAWP to IpcPH-LHD, but more severe RV–PA uncoupling, greater ventricular interaction, and more severe impairments in cardiac output, O2 delivery, and peak O2 consumption. Despite higher PVR, participants with CpcPH developed more severe lung congestion compared with both IpcPH-LHD and controls, which was associated lower arterial O2 tension, reduced alveolar ventilation, decreased pulmonary O2 diffusion, and greater ventilation-perfusion mismatch. Conclusions Pulmonary vascular disease in LHD is associated with a distinct pathophysiologic signature marked by greater exercise-induced lung congestion, arterial hypoxaemia, RV–PA uncoupling, ventricular interdependence, and impairment in O2 delivery, impairing aerobic capacity. Further study is required to identify novel treatments targeting the pulmonary vasculature in PH-LHD.
Hypoglycemia in Prospective Multicenter Study of Pregnancies with Pre-Existing Type 1 Diabetes on Sensor-Augmented Pump Therapy: The LOIS-P Study
Kaur, Ravinder Jeet , Özaslan, Başak , Pinsker, Jordan E. , Trinidad, Mari Charisse, O’Malley, Grenye , Desjardins, Donna, Castorino, Kristin , Levister, Camilla, Reid, Corey, McCrady-Spitzer, Shelly , Ogyaadu, Selassie, Church, Mei Mei , Piper, Molly, Kremers, Walter K. , Rosenn, Barak, Dassau, Eyal , Kudva, Yogish C. , Doyle, Francis J , Dassau, Eyal , Kudva, Yogish C. , Kremers, Walter K , Smith, Byron H. , Doyle, Francis J. , Levy, Carol J.

Mayo Clinic

Diabetes Technology & Therapeutics | March 29, 2022 | Volume: 24 | Issue: 8 | Pages: 544-555

10.1089/dia.2021.0479 | PMID 35349353 Get It

Background: Pregnancies in type 1 diabetes are high risk, and data in the United States are limited regarding continuous glucose monitoring (CGM)-based hypoglycemia throughout pregnancy while on sensor-augmented insulin pump therapy. Materials and Methods: Pregnant women with type 1 diabetes in the LOIS-P Study (Longitudinal Observation of Insulin use and glucose Sensor metrics in Pregnant women with type 1 diabetes using continuous glucose monitors and insulin pumps) were enrolled before 17 weeks gestation at three U.S. centers and we used their personal insulin pump and a study Dexcom G6 CGM. We analyzed data of 25 pregnant women for CGM hypoglycemia based on international consensus guidelines for percentage time <63 and 54 mg/dL, hypoglycemic events and prolonged hypoglycemia events for 24-h, daytime, and overnight periods, and severe hypoglycemia (SH) episodes. Results: For a 24-h period, biweekly median percentage of time <63 mg/dL ranged from 0.8% at biweek 4–5 to 3.7% at biweek 14–15 with high variability throughout pregnancy. Median percentage of time <63 and 54 mg/dL was higher overnight than daytime ( P < 0.01). Hypoglycemic events occurred throughout the pregnancy, ranged 1–4 events per 2 weeks, significantly decreased after the 20th week, and occurred predominantly during daytime ( P < 0.01). For overnight period, hypoglycemia and events were more concentrated from 12 to 3 am. Seven prolonged hypoglycemia events without any associated SH occurred in four participants (16%), primarily overnight. Three participants experienced a single episode of SH. Conclusions: Our results suggest a higher overall risk of hypoglycemia throughout pregnancy during the overnight period with continued daytime risk of hypoglycemic events in pregnancies complicated by type 1 diabetes.
A Scoping Review of Labor and Organ Trafficking Resources for U.S. Healthcare Professionals
Talbott, Jennifer , Titchen, KE, Mishra, N, Kling, JM, Talbott, Jennifer M V

Mayo Clinic

Journal of Human Trafficking | March 29, 2022 | Volume: 10 | Issue: 3 | Pages: 465-478

10.1080/23322705.2022.2054616 Get It

Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials
Chen, Jui‐Yi , Pan, Heng‐Chih , Hsieh, Chih-Chieh , Hsu, Tsuen‐Wei , Huang, Yun‐Ting , Huang, Tao‐Min , Huang, Chun-Te , Chen, Yung‐Ming , Shiao, Chih‐Chung , Kashani, Kianoush , Wu, Vin‐Cent

Mayo Clinic

Clinical Kidney Journal | March 29, 2022 | Volume: 15 | Issue: 5 | Pages: 1027-1027

10.1093/ckj/sfac059 | PMID 35503545 Get It

Unilateral Optic Nerve Diffusion Restriction After Sinus Surgery Secondary to Central Retinal Artery Occlusion
Parikh, Parth P., Harahsheh, Ehab Y., Dumitrascu, Oana M., Parikh, Parth , Parikh, Parth , Parikh, Parth P., Harahsheh, Ehab Y., Dumitrascu, Oana M.

Mayo Clinic

The Neurologist | March 29, 2022 | Volume: 28 | Issue: 1 | Pages: 46-48

10.1097/nrl.0000000000000433 | PMID 35348478 Get It

Introduction: Permanent perioperative vision loss is caused by ischemic optic neuropathy (ION) or central retinal artery occlusion (CRAO). Whereas diffusion restriction of the optic nerve (ON) on brain magnetic resonance imaging has been previously reported in perioperative posterior ION (PION), there are no reports of ON diffusion restriction in patients diagnosed with acute perioperative CRAO. We present a case of perioperative CRAO to highlight this neuroimaging finding for neuroradiologists and neurologists. Case Report: A 71-year-old male without vascular risk factors underwent maxillary bilateral antrostomy and septoplasty for chronic sinusitis. Twenty to thirty minutes upon awakening, he complained of painless left eye vision loss. Ophthalmoscopic examination showed retinal whitening, segmented arterioles, and hyperemic disc. Brain MR-diffusion weighted imaging/apparent diffusion coefficient revealed ON diffusion restriction in the proximal segment. Despite attempted reperfusion, left eye remained with no light perception at 6 months. Patients undergoing nonocular surgeries who develop perioperative vision loss related to PION may exhibit ON diffusion restriction but usually have normal ophthalmoscopic findings. CRAO shows retinal whitening, edema, segmentation of arterioles, and cherry red spot on ophthalmoscopy. A recent study reported that ON diffusion restriction in nonperioperative CRAO cases has a sensitivity and specificity of 55% and 70% to 100%. Here, PION was initially considered based on imaging. However, given the neuro-ophthalmic findings, a proximal embolus in the central retinal artery, obstructing its entrance into the proximal ON was deemed more likely. Conclusion: We highlight that proximal ON diffusion restriction on brain magnetic resonance imaging can be diagnostic of proximal thromboembolic CRAO. Future studies should evaluate the diagnostic utility and accuracy of MR-diffusion weighted imaging/apparent diffusion coefficient in perioperative visual loss.
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Klonoff, David C. , Wang, Jing , Rodbard, David , Kohn, Michael A. , Li, Chengdong , Liepmann, Dorian , Kerr, David , Ahn, David , Peters, Anne L. , Umpierrez, Guillermo E. , Xu, Nicole Y. , Nguyen, Kevin T. , Simonson, Gregg D. , Agus, Michael S. D. , Armaiz-Peña, Gustavo , Basu, Ananda , Battelino, Tadej , Yeshiwas, Sewagegn , Bequette, B. Wayne , Blevins, Thomas , Breton, Marc D. , Castle, Jessica R. , Close, Kelly L. , Drincic, Angela, Dungan, Kathleen , Ejskjær, Niels , Espinoza, Juan , Fleming, G. Alexander , Forlenza, Gregory P. , Freckmann, Guido , Galindo, Rodolfo J. , Gómez, Ana María , Gutow, Hanna A. , Hovorka, Roman , Ji, Linong , Joubert, Michaël , Koliwad, Suneil K. , Lal, Rayhan , Lansang, M. Cecilia , Lee, Wei-An , Leelarathna, Lalantha , Lind, Marcus , Mahoney, Katherine , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras , Mayorov, Alexander Yur'evich , Messler, Jordan , Mohan, Viswanathan , Nichols, James H. , O’Neal, David N. , Pasquel, Francisco J. , Philis‐Tsimikas, Athena , Phillip, Moshe , Rayman, Gerry , Russell, Steven J. , Spanakis, Elias K. , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E. , Wolpert, Howard , Zilbermint, Mihail , Kovatchev, Boris , Seley, Jane Jeffrie , Xu, Nicole Y , Nguyen, Kevin T , Simonson, Gregg , Agus, Michael S D , Al-Sofiani, Mohammed E , Armaiz-Pena, Gustavo , Bailey, Timothy S , Basu, Ananda , Battelino, Tadej , Bekele, Sewagegn Yeshiwas , Benhamou, Pierre-Yves , Bequette, B Wayne , Blevins, Thomas , Breton, Marc D , Castle, Jessica R , Chase, James Geoffrey , Chen, Kong , Choudhary, Pratik , Clements, Mark A , Close, Kelly L , Cook, Curtiss B , Doyle, Francis J , Drincic, Angela , Dungan, Kathleen M , Edelman, Steven V , Ejskjaer, Niels , Espinoza, Juan , Fleming, G Alexander , Forlenza, Gregory P , Freckmann, Guido , Galindo, Rodolfo J , Gomez, Ana Maria , Gutow, Hanna A , Heinemann, Lutz , Hirsch, Irl B , Hoang, Thanh D , Hovorka, Roman , Jendle, Johan H , Ji, Linong , Joshi, Shashank R , Joubert, Michael , Koliwad, Suneil K , Lal, Rayhan A , Lansang, M Cecilia , Lee, Wei-An Andy , Leelarathna, Lalantha , Leiter, Lawrence A , Lind, Marcus , Litchman, Michelle L , Mader, Julia K , Mahoney, Katherine M , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras N , Mayorov, Alexander , Messler, Jordan , Miller, Joshua D , Mohan, Viswanathan , Nichols, James H , Nørgaard, Kirsten , O'Neal, David N , Pasquel, Francisco J , Philis-Tsimikas, Athena , Pieber, Thomas , Phillip, Moshe , Polonsky, William H , Pop-Busui, Rodica , Rayman, Gerry , Rhee, Eun-Jung , Russell, Steven J , Shah, Viral N , Sherr, Jennifer L , Sode, Koji , Spanakis, Elias K , Wake, Deborah J , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E , Wolpert, Howard , Wright, Eugene E , Zilbermint, Mihail , Kovatchev, Boris , Kohn, Michael , Umpierrez, Guillermo E. , Peters, Anne L , Ahn, David T , Liepmann, Dorian , Bailey, Timothy S. , Chen, Kong Y. , Choudhary, Pratik , Cook, Curtiss B. , Danne, Thomas , Doyle, Francis J. , Heinemann, Lutz , Hirsch, Irl B. , Leiter, Lawrence A. , Mader, Julia K. , Pop‐Busui, Rodica , Shah, Viral N. , Sode, Koji , Wright, Eugene E.

Mayo Clinic

Journal of Diabetes Science and Technology | March 29, 2022 | Volume: 17 | Issue: 5 | Pages: 1226-1242

10.1177/19322968221085273 | PMID 35348391 Get It

Background: A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data. Methods: We assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low–glucose and low-glucose hypoglycemia; very high–glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation. Results: The analysis showed that clinician rankings depend on two components, one related to hypoglycemia that gives more weight to very low-glucose than to low-glucose and the other related to hyperglycemia that likewise gives greater weight to very high-glucose than to high-glucose. These two components should be calculated and displayed separately, but they can also be combined into a single Glycemia Risk Index (GRI) that corresponds closely to the clinician rankings of the overall quality of glycemia (r = 0.95). The GRI can be displayed graphically on a GRI Grid with the hypoglycemia component on the horizontal axis and the hyperglycemia component on the vertical axis. Diagonal lines divide the graph into five zones (quintiles) corresponding to the best (0th to 20th percentile) to worst (81st to 100th percentile) overall quality of glycemia. The GRI Grid enables users to track sequential changes within an individual over time and compare groups of individuals. Conclusion: The GRI is a single-number summary of the quality of glycemia. Its hypoglycemia and hyperglycemia components provide actionable scores and a graphical display (the GRI Grid) that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.
Identification of Incident Atrial Fibrillation From Electronic Medical Records
Chamberlain, Alanna M. , Roger, Véronique L. , Noseworthy, Peter A. , Weston, Susan A., Jiang, Ruoxiang , Alonso, Álvaro , Chen, Lin Y , Alonso, Alvaro , Noseworthy, Peter A , Chamberlain, Alanna M , Chen, Lin Y.

Mayo Clinic

Journal of the American Heart Association | March 29, 2022 | Volume: 11 | Issue: 7 | Pages: No page available

10.1161/jaha.121.023237 | PMID 35348008 Get It

Background Electronic medical records are increasingly used to identify disease cohorts; however, computable phenotypes using electronic medical record data are often unable to distinguish between prevalent and incident cases. Methods and Results We identified all Olmsted County, Minnesota residents aged ≥18 with a first‐ever International Classification of Diseases, Ninth Revision (ICD‐9) diagnostic code for atrial fibrillation or atrial flutter from 2000 to 2014 (N=6177), and a random sample with an International Classification of Diseases, Tenth Revision (ICD‐10) code from 2016 to 2018 (N=200). Trained nurse abstractors reviewed all medical records to validate the events and ascertain the date of onset (incidence date). Various algorithms based on number and types of codes (inpatient/outpatient), medications, and procedures were evaluated. Positive predictive value (PPV) and sensitivity of the algorithms were calculated. The lowest PPV was observed for 1 code (64.4%), and the highest PPV was observed for 2 codes (any type) >7 days apart but within 1 year (71.6%). Requiring either 1 inpatient or 2 outpatient codes separated by >7 days but within 1 year had the best balance between PPV (69.9%) and sensitivity (95.5%). PPVs were slightly higher using ICD‐10 codes. Requiring an anticoagulant or antiarrhythmic prescription or electrical cardioversion in addition to diagnostic code(s) modestly improved the PPVs at the expense of large reductions in sensitivity. Conclusions We developed simple, exportable, computable phenotypes for atrial fibrillation using structured electronic medical record data. However, use of diagnostic codes to identify incident atrial fibrillation is prone to some misclassification. Further study is warranted to determine whether more complex phenotypes, including unstructured data sources or using machine learning techniques, may improve the accuracy of identifying incident atrial fibrillation.
Bench valvular surgery in donor hearts before transplantation: Choice versus Necessity
Ahmed, Magdy M. El‐Sayed , Pham, Anthony , Sareyyüpoğlu, Başar , Pham, Anthony, Pham, Si M.

Mayo Clinic

No container title available | March 29, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.164854801.13643243/v1 Get It

Severe shortage of donor hearts has increased the mortality of patients on the transplant waiting list. However, donor hearts with valvular dysfunction are rarely used. Utilizing donor hearts with valvular lesions that can be repaired or replaced at the time of transplant will decrease waitlist mortality and offer many patients a second chance in life.